Tuesday 27 September 2016

Verification vs validation is a key understanding for regulatory professionals

For regulatory professionals, aspects of verification and validation, such as how to get verification and validation right, and an understanding of the ways in which verification and validation diverge from each other and converge, make up very important learning. The key point is that verification and validation should be risk based and be built keeping in mind the extant regulatory expectations.

Building a verification and validation process that sufficiently uses targeted and documented risk based verification and validation test case elements or scripts is the foundation to this. All these have to be reviewed against ISO 14971 and ICH Q 9 hazard analysis and product risk management.

Getting their V & V right involves gaining and exercising proper knowledge of these areas on the part of professionals working in regulatory environments. This learning is what a two-day seminar by GlobalCompliancePanel, a very well-known provider of professional trainings for all the areas of regulatory compliance, will impart.

V & V against the regulatory process

The Director of this seminar, John E Lincoln, a senior Consultant for Medical device and Regulatory Affairs, will explain the rationale behind verification and validation and clear all the ambiguities relating to this activity.

He will help participants to understand the following:

o   Evaluating different field-tested, U.S. FDA-reviewed V&V protocols
o   Ways by which to employ equipment/process Requirements Specs/DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500. John E Lincoln will help participants how to do all these against a background of limited company resources
o   Reviewing a matrix that simplifies “as-product”, “in-product”, process and equipment and related matters
o   Software VT&V to ensure that key FDA requirements are not overlooked
To enroll for this course, just log on to

The Director will also offer hands-on understanding of Quality Management Systems and 21 CFR Part 11. This seminar will help participants:
o   Understand Verification and Validation, differences and how they work together;
o   Discuss recent regulatory expectations;
o   Know how to document a "risk-based" rationale, and use it in a resource-constrained environment;
o   Determine key "milestones" and "tasks" in a project;
o   Locate and document key subject "inputs";
o   Compile "generic" Master and Individual Validation Plans;
o   Learn the key element of a Product V&V File/Protocol;
o   Understand how to develop Process and/or Production/Test Equipment V&V Files/Protocols;
o   Get a grasp of basic Test Case construction;
o   Understand sample sizes and their justification;
o   Learn the key elements of Software V&V expected by the FDA and how to document;
o   Deal with hardware and software vendors, sales and marketing
o   Consider a field-tested software V&V documentation "model";
o   See how to compile QMS Electronic Records and Electronic Signatures V&Vs to satisfy 21 CFR Part 11.















Labels: , , , , , , ,

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home